ADDvise Group AB (publ) (ADDV-A.ST)
SEK 11.2
(1.36%)
SEK 11.2
(1.36%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 3.28 Billion SEK | 66.98% |
| 2022 | 1.96 Billion SEK | 84.1% |
| 2021 | 1.06 Billion SEK | 209.32% |
| 2020 | 345.74 Million SEK | -4.06% |
| 2019 | 360.36 Million SEK | 23.74% |
| 2018 | 291.22 Million SEK | 4.87% |
| 2017 | 277.69 Million SEK | 23.71% |
| 2016 | 224.47 Million SEK | 74.08% |
| 2015 | 128.95 Million SEK | -22.57% |
| 2014 | 166.54 Million SEK | 90.58% |
| 2013 | 87.39 Million SEK | 28.81% |
| 2012 | 67.84 Million SEK | 189.77% |
| 2011 | 23.41 Million SEK | 8.8% |
| 2010 | 21.52 Million SEK | 0.0% |
| 2008 | 12.91 Million SEK | 9.79% |
| 2007 | 11.76 Million SEK | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 3.4 Billion SEK | 3.58% |
| 2024 Q3 | 3.37 Billion SEK | -3.58% |
| 2024 Q2 | 3.49 Billion SEK | 2.74% |
| 2023 Q2 | 2.5 Billion SEK | 28.14% |
| 2023 Q1 | 1.95 Billion SEK | -0.65% |
| 2023 Q3 | 2.38 Billion SEK | -4.89% |
| 2023 FY | 3.28 Billion SEK | 66.98% |
| 2023 Q4 | 3.28 Billion SEK | 37.9% |
| 2022 Q4 | 1.96 Billion SEK | 29.99% |
| 2022 FY | 1.96 Billion SEK | 84.1% |
| 2022 Q1 | 1.25 Billion SEK | 17.08% |
| 2022 Q2 | 1.43 Billion SEK | 15.0% |
| 2022 Q3 | 1.51 Billion SEK | 5.18% |
| 2021 Q3 | 739.11 Million SEK | 34.94% |
| 2021 Q4 | 1.06 Billion SEK | 44.69% |
| 2021 Q1 | 372.06 Million SEK | 7.61% |
| 2021 Q2 | 547.73 Million SEK | 47.21% |
| 2021 FY | 1.06 Billion SEK | 209.32% |
| 2020 Q2 | 355.24 Million SEK | 1.43% |
| 2020 Q4 | 345.74 Million SEK | 0.65% |
| 2020 Q3 | 343.51 Million SEK | -3.3% |
| 2020 Q1 | 350.25 Million SEK | -2.81% |
| 2020 FY | 345.74 Million SEK | -4.06% |
| 2019 FY | 360.36 Million SEK | 23.74% |
| 2019 Q4 | 360.36 Million SEK | 0.86% |
| 2019 Q2 | 352.78 Million SEK | 5.78% |
| 2019 Q1 | 333.49 Million SEK | 14.52% |
| 2019 Q3 | 357.3 Million SEK | 1.28% |
| 2018 FY | 291.22 Million SEK | 4.87% |
| 2018 Q4 | 291.22 Million SEK | 0.91% |
| 2018 Q3 | 288.59 Million SEK | 6.3% |
| 2018 Q2 | 271.49 Million SEK | -1.71% |
| 2018 Q1 | 276.2 Million SEK | -0.54% |
| 2017 Q4 | 277.69 Million SEK | 10.3% |
| 2017 Q3 | 251.76 Million SEK | 2.86% |
| 2017 Q2 | 244.77 Million SEK | 7.8% |
| 2017 Q1 | 227.06 Million SEK | 1.15% |
| 2017 FY | 277.69 Million SEK | 23.71% |
| 2016 Q4 | 224.47 Million SEK | 15.54% |
| 2016 Q3 | 194.28 Million SEK | 1.68% |
| 2016 Q2 | 191.08 Million SEK | 2.18% |
| 2016 Q1 | 187 Million SEK | 45.02% |
| 2016 FY | 224.47 Million SEK | 74.08% |
| 2015 Q1 | 166.91 Million SEK | 0.22% |
| 2015 Q2 | 147.47 Million SEK | -11.64% |
| 2015 Q4 | 128.95 Million SEK | -5.76% |
| 2015 Q3 | 136.83 Million SEK | -7.21% |
| 2015 FY | 128.95 Million SEK | -22.57% |
| 2014 FY | 166.54 Million SEK | 90.58% |
| 2014 Q4 | 166.54 Million SEK | 69.34% |
| 2014 Q3 | 98.35 Million SEK | -3.85% |
| 2014 Q2 | 102.29 Million SEK | 4.6% |
| 2014 Q1 | 97.79 Million SEK | 11.91% |
| 2013 Q3 | 87.69 Million SEK | 30.78% |
| 2013 Q4 | 87.39 Million SEK | -0.34% |
| 2013 FY | 87.39 Million SEK | 28.81% |
| 2013 Q1 | 61.9 Million SEK | -8.75% |
| 2013 Q2 | 67.05 Million SEK | 8.31% |
| 2012 Q3 | 64.72 Million SEK | 0.24% |
| 2012 FY | 67.84 Million SEK | 189.77% |
| 2012 Q1 | 44.78 Million SEK | 91.3% |
| 2012 Q4 | 67.84 Million SEK | 4.82% |
| 2012 Q2 | 64.56 Million SEK | 44.17% |
| 2011 Q4 | 23.41 Million SEK | 14.44% |
| 2011 FY | 23.41 Million SEK | 8.8% |
| 2011 Q2 | 19.93 Million SEK | 3.9% |
| 2011 Q1 | 19.18 Million SEK | -10.87% |
| 2011 Q3 | 20.45 Million SEK | 2.65% |
| 2010 Q2 | 10.55 Million SEK | 76.42% |
| 2010 FY | 21.52 Million SEK | 0.0% |
| 2010 Q1 | 5.98 Million SEK | 0.0% |
| 2010 Q4 | 21.52 Million SEK | 92.42% |
| 2010 Q3 | 11.18 Million SEK | 5.96% |
| 2009 Q1 | 12.91 Million SEK | 15.66% |
| 2009 Q2 | 10.98 Million SEK | -15.0% |
| 2008 FY | 12.91 Million SEK | 9.79% |
| 2008 Q4 | 11.17 Million SEK | 0.0% |
| 2008 Q1 | 11.76 Million SEK | 0.0% |
| 2007 FY | 11.76 Million SEK | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Acarix AB (publ) | 62.88 Million SEK | -5127.721% |
| ADDvise Group AB (publ) | 3.28 Billion SEK | 0.0% |
| Arcoma AB | 81.96 Million SEK | -3910.883% |
| Bactiguard Holding AB (publ) | 682.87 Million SEK | -381.404% |
| BICO Group AB (publ) | 10.19 Billion SEK | 67.76% |
| Boule Diagnostics AB (publ) | 755.1 Million SEK | -335.36% |
| CellaVision AB (publ) | 928.71 Million SEK | -253.974% |
| Clinical Laserthermia Systems AB (publ) | 57.72 Million SEK | -5594.933% |
| Chordate Medical Holding AB (publ) | 21.95 Million SEK | -14873.029% |
| C-Rad AB (publ) | 404 Million SEK | -713.713% |
| Duearity AB (publ) | 15.14 Million SEK | -21607.607% |
| Dignitana AB (publ) | 44.83 Million SEK | -7232.872% |
| Episurf Medical AB (publ) | 104.3 Million SEK | -3051.87% |
| Getinge AB (publ) | 55.09 Billion SEK | 94.034% |
| Scandinavian Real Heart AB (Publ) | 102.63 Million SEK | -3102.899% |
| Iconovo AB (publ) | 128.07 Million SEK | -2466.679% |
| Integrum AB (publ) | 164.85 Million SEK | -1894.066% |
| Luxbright AB (publ) | 40.68 Million SEK | -7979.798% |
| Mentice AB (publ) | 322.52 Million SEK | -919.267% |
| OssDsign AB (publ) | 356.38 Million SEK | -822.419% |
| Paxman AB (publ) | 167.12 Million SEK | -1867.031% |
| Promimic AB (publ) | 92.87 Million SEK | -3439.596% |
| Qlife Holding AB (publ) | 39.04 Million SEK | -8319.3% |
| SciBase Holding AB (publ) | 64.33 Million SEK | -5009.895% |
| ScandiDos AB (publ) | 81.47 Million SEK | -3934.956% |
| Sectra AB (publ) | 3.21 Billion SEK | -2.381% |
| Sedana Medical AB (publ) | 1.01 Billion SEK | -224.183% |
| Senzime AB (publ) | 433.54 Million SEK | -658.266% |
| SpectraCure AB (publ) | 144.83 Million SEK | -2169.771% |
| Stille AB | 804.89 Million SEK | -308.426% |
| Vitrolife AB (publ) | 16.39 Billion SEK | 79.944% |
| Xvivo Perfusion AB (publ) | 2.19 Billion SEK | -49.726% |